A Study to Evaluate the Efficacy and Safety of Mizoribine in the Treatment of Lupus Nephritis
Status:
Completed
Trial end date:
2019-03-01
Target enrollment:
Participant gender:
Summary
To demonstrate that the treatment effect in lupus nephritis of MZR is non-inferior to that of
standard therapy CTX through analyzing overall remission rate after treatment.